Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 11 Mar 24 EFFECT Notice of effectiveness
- 1 Mar 24 POS AM Prospectus update (post-effective amendment)
- 8 Nov 23 424B3 Prospectus supplement
- 4 May 23 424B3 Prospectus supplement
- 27 Mar 23 EFFECT Notice of effectiveness
- 23 Mar 23 POS AM Prospectus update (post-effective amendment)
- 9 Nov 22 424B3 Prospectus supplement
- 3 Aug 22 424B3 Prospectus supplement
- 27 Jun 22 424B3 Prospectus supplement
- 27 Jun 22 EFFECT Notice of effectiveness
-
14 Jun 22 S-1 IPO registration
Associated GOVX transcripts
GOVX similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use in this Registration Statement on Form S-1 of GeoVax Labs, Inc. of our report dated March 9, 2022, relating to the 2021 consolidated financial statements of GeoVax Labs, Inc. which report expresses an unqualified opinion, appearing in the Prospectus, which is part of this Registration Statement, and of our report dated March 9, 2022 relating to the financial statement schedule appearing elsewhere in this Registration Statement. We also consent to the reference to our firm under the heading “Experts” in such Prospectus.
/s/ Wipfli LLP
Atlanta, Georgia
June 14, 2022